Tumor suppressor p53 is required to modulate BRCA1 expression

被引:89
作者
Arizti, P
Fang, L
Park, I
Yin, YX
Solomon, E
Ouchi, T
Aaronson, SA
Lee, SW
机构
[1] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA
[2] Beth Israel Deaconess Med Ctr, Harvard Inst Med, Boston, MA 02215 USA
[3] CUNY Mt Sinai Sch Med, Derald H Ruttenberg Canc Ctr, New York, NY 10029 USA
[4] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA
[5] UMDS, Guys Hosp, Div Med & Mol Genet, London SE1 9RT, England
关键词
D O I
10.1128/MCB.20.20.7450-7459.2000
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Individuals carrying mutations in BRCA1 or p53 genes are predisposed to a variety of cancers, and both tumor suppressor genes have been implicated in DNA damage response pathways. We have analyzed a possible functional link between p53 and BRCA1 genes. Here we show that BRCA1 expression levels are down-regulated in response to p53 induction in cells that undergo either growth arrest, senescence, or apoptosis. Physiological stimuli, such as exposure to DNA-damaging agents, also result in negative regulation of BRCA1 levels in a p53-dependent manner prior to causing cell cycle arrest. Nuclear run-on experiments and luciferase reporter assays demonstrate that the changes in BRCA1 expression are mainly due to transcriptional repression induced by p53. In conclusion, the data show that BRCA1 expression levels are controlled by the presence and activity of wild-type p53 and suggest the existence of an intracellular p53/BRCA1 pathway in the response of cells to stress conditions.
引用
收藏
页码:7450 / 7459
页数:10
相关论文
共 67 条
  • [1] The p53 network
    Agarwal, ML
    Taylor, WR
    Chernov, MV
    Chernova, OB
    Stark, GR
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (01) : 1 - 4
  • [2] [Anonymous], CURRENT PROTOCOLS MO
  • [3] DISTINCTIVE TRAITS OF NORMAL AND TUMOR-DERIVED HUMAN MAMMARY EPITHELIAL-CELLS EXPRESSED IN A MEDIUM THAT SUPPORTS LONG-TERM GROWTH OF BOTH CELL-TYPES
    BAND, V
    SAGER, R
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (04) : 1249 - 1253
  • [4] BRAWERMAN G, 1993, CONTROL MESSENGER RN
  • [5] MUTATIONS IN THE BRCA1 GENE IN FAMILIES WITH EARLY-ONSET BREAST AND OVARIAN-CANCER
    CASTILLA, LH
    COUCH, FJ
    ERDOS, MR
    HOSKINS, KF
    CALZONE, K
    GARBER, JE
    BOYD, J
    LUBIN, MB
    DESHANO, ML
    BRODY, LC
    COLLINS, FS
    WEBER, BL
    [J]. NATURE GENETICS, 1994, 8 (04) : 387 - 391
  • [6] The second BRCT domain of BRCA-1 proteins interacts with p53 and stimulates transcription from the p21WAF1/CIP1 promoter
    Chai, YL
    Cui, JQ
    Shao, NS
    Reddy, ESP
    Rao, VN
    [J]. ONCOGENE, 1999, 18 (01) : 263 - 268
  • [7] Chen JD, 1996, MOL CELL BIOL, V16, P2445
  • [8] Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells
    Chen, JJ
    Silver, DP
    Walpita, D
    Cantor, SB
    Gazdar, AF
    Tomlinson, G
    Couch, FJ
    Weber, BL
    Ashley, T
    Livingston, DM
    Scully, R
    [J]. MOLECULAR CELL, 1998, 2 (03) : 317 - 328
  • [9] ACCUMULATION OF P53 IN A MUTANT-CELL LINE DEFECTIVE IN THE UBIQUITIN PATHWAY
    CHOWDARY, DR
    DERMODY, JJ
    JHA, KK
    OZER, HL
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (03) : 1997 - 2003
  • [10] Requirement of ATM-dependent phosphorylation of BRCA1 in the DNA damage response to double-strand breaks
    Cortez, D
    Wang, Y
    Qin, J
    Elledge, SJ
    [J]. SCIENCE, 1999, 286 (5442) : 1162 - 1166